Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hayes

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Neuro-Oncology|February 13, 2007
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium reportIan F Pollack, Regina I Jakacki, Susan M Blaney, et al.
Journal of Neuroscience Research|November 10, 2022
Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicityGabrielle Todd, Caroline D Rae, Janet L Taylor, et al.
Annals of Clinical and Translational Neurology|February 26, 2025
Targeted Long-Read Sequencing as a Single Assay Improves the Diagnosis of Spastic-Ataxia DisordersLaura Ivete Rudaks, Igor Stevanovski, Dennis Yeow, et al.
Parkinsonism & Related Disorders|November 16, 2019
Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypesKishore R Kumar, Ryan L Davis, Michel C Tchan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Parkinsonism & Related Disorders|May 21, 2024
Genome sequencing reanalysis increases the diagnostic yield in dystoniaAvi Fellner, Gurusidheshwar M Wali, Neil Mahant, et al.
Brain : a Journal of Neurology|September 9, 2016
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsAnine H Stam, Parul H Kothari, Aisha Shaikh, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Neuro-Oncology|February 13, 2007
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium reportIan F Pollack, Regina I Jakacki, Susan M Blaney, et al.
Journal of Neuroscience Research|November 10, 2022
Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicityGabrielle Todd, Caroline D Rae, Janet L Taylor, et al.
Annals of Clinical and Translational Neurology|February 26, 2025
Targeted Long-Read Sequencing as a Single Assay Improves the Diagnosis of Spastic-Ataxia DisordersLaura Ivete Rudaks, Igor Stevanovski, Dennis Yeow, et al.
Parkinsonism & Related Disorders|November 16, 2019
Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypesKishore R Kumar, Ryan L Davis, Michel C Tchan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Parkinsonism & Related Disorders|May 21, 2024
Genome sequencing reanalysis increases the diagnostic yield in dystoniaAvi Fellner, Gurusidheshwar M Wali, Neil Mahant, et al.
Brain : a Journal of Neurology|September 9, 2016
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsAnine H Stam, Parul H Kothari, Aisha Shaikh, et al.
Pageof 10